• Avalyn Pharma appointed Robert J. Meyer to its board of directors.
• Meyer is a pulmonary physician. He most recently served as principal of Drug and Biologics Products at Greenleaf Health.
• He previously held senior FDA roles, including Director of the Office of Drug Evaluation II, later serving as a vice president at Merck Research Laboratories.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalyn Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609161601PRIMZONEFULLFEED9828346) on September 16, 2026, and is solely responsible for the information contained therein.